Virus Dataset Sample Info

> Dataset: 26593963 Search Result


Summary
Item Summary
Project 26593963
Virus Name EBV
Sample Number 12
Disease Burkitt lymphoma
Country Brazil;Argentina;Ghana
Data Link https://www.ncbi.nlm.nih.gov/nuccore/?term=KP968257:KP968264[pacc]
https://www.ncbi.nlm.nih.gov/nuccore/?term=KR063342:KR063345[pacc]

Sample
ID Sample ID Age Gender Origin Detail
1 CCH 4 M Brazil View
2 MP 4 M Brazil View
3 SCL 6 F Brazil View
4 VGO 5 M Brazil View
5 RPF 11 M Brazil View
6 FNR 6 M Brazil View
7 CV-ARG 7 F Argentina View
8 HU11393 (K00091800) 7.23 M Ghana View
9 H03753A (K00091800) 7.23 M Ghana View
10 H018436D (K00062500) 5.06 M Ghana View
11 H058015C (K00126500) 12.1 F Ghana View
12 H002213 (K00094200) 7.61 M Ghana View

Seq Data
GeneBank/SRA/GEO/ENA/EGA ID URL
KP968257 https://www.ncbi.nlm.nih.gov/nuccore/?term=KP968257
KP968258 https://www.ncbi.nlm.nih.gov/nuccore/?term=KP968258
KP968259 https://www.ncbi.nlm.nih.gov/nuccore/?term=KP968259
KP968260 https://www.ncbi.nlm.nih.gov/nuccore/?term=KP968260
KR063344 https://www.ncbi.nlm.nih.gov/nuccore/?term=KR063344
KR063345 https://www.ncbi.nlm.nih.gov/nuccore/?term=KR063345
KR063343 https://www.ncbi.nlm.nih.gov/nuccore/?term=KR063343
KP968261 https://www.ncbi.nlm.nih.gov/nuccore/?term=KP968261
KR063342 https://www.ncbi.nlm.nih.gov/nuccore/?term=KR063342
KP968262 https://www.ncbi.nlm.nih.gov/nuccore/?term=KP968262
KP968263 https://www.ncbi.nlm.nih.gov/nuccore/?term=KP968263
KP968264 https://www.ncbi.nlm.nih.gov/nuccore/?term=KP968264

Literature
Item Summary
PMID 26593963
Title Epstein-Barr virus from Burkitt Lymphoma biopsies from Africa and South America share novel LMP-1 promoter and gene variations.
Abstract Epstein Barr virus (EBV) sequence variation is thought to contribute to Burkitt lymphoma (BL), but lack of data from primary BL tumors hampers efforts to test this hypothesis. We directly sequenced EBV from 12 BL biopsies from Ghana, Brazil, and Argentina, aligned the obtained reads to the wild-type (WT) EBV reference sequence, and compared them with 100 published EBV genomes from normal and diseased people from around the world. The 12 BL EBVs were Type 1. Eleven clustered close to each other and to EBV from Raji BL cell line, but away from 12 EBVs reported from other BL-derived cell lines and away from EBV from NPC and healthy people from Asia. We discovered 23 shared novel nucleotide-base changes in the latent membrane protein (LMP)-1 promoter and gene (associated with 9 novel amino acid changes in the LMP-1 protein) of the 11 BL EBVs. Alignment of this region for the 112 EBV genomes revealed four distinct patterns, tentatively termed patterns A to D. The distribution of BL EBVs was 48%, 8%, 24% and 20% for patterns A to D, respectively; the NPC EBV's were Pattern B, and EBV-WT was pattern D. Further work is needed to investigate the association between EBV LMP-1 patterns with BL.